When it comes to acquisitions, “goodwill”, as the author of today’s article explains, “represents the premium an acquiring company paid over an acquisition target’s net book value, and can face massive writedowns if the underlying business goes bad.” He proceeds to flag two healthcare companies that, due to acquisitions that ended up being poorly timed thanks to the effects of the novel coronavirus, are at high risk of substantial writedowns – and thus whose stock it may be best to avoid. For more, CLICK HERE.